New Key Statistics Module, Z-Score and F-Score
NAS:TBPH Key Ratios
Market Cap $ M | 445.78 |
Enterprise Value $ M | 390.09 |
P/E(ttm) | -- |
PE Ratio without NRI | -- |
Forward PE Ratio | -- |
Price/Book | 2.07 |
Price/Sales | 8.62 |
Price/Free Cash Flow | -- |
Price/Owner Earnings | -- |
Payout Ratio % | -- |
Revenue (TTM) $ M | 57.00 |
EPS (TTM) $ | -0.97 |
Beneish M-Score | -2.61 |
10-y EBITDA Growth Rate % | 14.90 |
5-y EBITDA Growth Rate % | 29.20 |
y-y EBITDA Growth Rate % | -- |
EV-to-EBIT | -8.31 |
EV-to-EBITDA | -9.14 |
PEG | -- |
Shares Outstanding M | 48.56 |
Net Margin (%) | -96.12 |
Operating Margin % | -94.05 |
Pre-tax Margin (%) | -85.80 |
Quick Ratio | 5.39 |
Current Ratio | 5.39 |
ROA % (ttm) | -11.56 |
ROE % (ttm) | -17.79 |
ROIC % (ttm) | -22.71 |
Dividend Yield % | -- |
Altman Z-Score | -1.67 |
TBPH Number of Guru Trades
TBPH Volume of Guru Trades
Gurus Latest Trades with NAS:TBPH
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
NAS:TBPH is held by these investors
Total 1
Theravance Biopharma Inc Insider Transactions
No Available Data
News about NAS:TBPH
Total 0- 1